Home
Conditions
Leukemia, Myelomonocytic, Chronic

Clinical trial condition

Leukemia, Myelomonocytic, Chronic

Explore clinical trials studying Leukemia, Myelomonocytic, Chronic. Study availability and eligibility vary by location and protocol.

416 public trials 60 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myelomonocytic, Chronic trial results

Recruiting

Study to Evaluate the Safety and Tolerability of EP0042

NCT04581512

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations: Royal Perth Hospital Perth, Western Australia, Australia

Amsterdam UMC Amsterdam, Netherlands

Erasmus MC Rotterdam, Netherlands

The Royal Marsden London, UK, United Kingdom

View Trial Details

Recruiting

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

NCT03128034

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +34 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

NCT03670966

Conditions: Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, +37 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Relevance of Peripheral Cells in the Pathophysiology of Chronic Myelomonocytic Leukemia (CMML)

NCT03280888

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +11 more
Locations: CHU de Nice Nice, France

View Trial Details

Recruiting

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

NCT05092451

Conditions: Acute Myeloid Leukemia (AML), B-cell Lymphoma, Blastic Transformation of Chronic Myeloid Leukemia, +39 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

NCT03964506

Conditions: Acute Myeloid Leukemia, Atypical Chronic Myeloid Leukemia, Bone Marrow Diseases, +21 more
Locations: Wilmot Cancer Institute, University of Rochester Rochester, New York, United States

View Trial Details

Recruiting

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

NCT04195633

Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +59 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia

NCT07588594

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia (CMML), +11 more
Locations: Peking University People's Hospital Beijing, China

View Trial Details

Recruiting

CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

NCT03896269

Conditions: Blasts 10-19 Percent of Bone Marrow Nucleated Cells, Blasts More Than 5 Percent of Bone Marrow Nucleated Cells, Bone Marrow Diseases, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

NCT04239157

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Leukemia, Myelomonocytic, Chronic

Leukemia, Myelomonocytic, Chronic trial results

Related conditions